Classification of the incidence of adverse events according to the recommendations of the World Health Organization (WHO):
very often> 1/10; often from> 1/100 to <1/10; infrequently from> 1/1000 to <1/100; rarely from> 1/10000 to <1/1000; very rarely <1/10000, including individual messages; the frequency is unknown - it is not possible to establish the frequency of occurrence from the available data.
Allergic reactions:
frequency is unknown - reactions of hypersensitivity, anaphylactic reactions (including anaphylactic shock), angioedema.
From the digestive system:
often - nausea, decreased sensitivity in the oral cavity or pharynx; infrequently - dyspepsia, vomiting, diarrhea, abdominal pain; rarely - heartburn, dryness of the mucous membrane of the mouth and throat, constipation.
From the respiratory system:
rarely - dryness of the mucous membrane of the respiratory tract, rhinorrhea (discharge of mucus from the nose).
From the skin:
rarely - skin rash, hives; frequency unknown - skin itching, Stevens-Johnson syndrome (multi-form exudative erythema), Lyell's syndrome (toxic epidermal necrolysis), acute generalized exanthematous pustulosis.
From the sense organs:
infrequently - dysgeusia (a violation of taste sensations).
Other:
rarely - weakness, headache, dysuria (urination disorders), hyperthermia, fever.